Researchers have developed an AI to diagnose up to 10 types of dementia, helping discuss cybernetic implants for dementia treatments.
Brain-Computer Interface
The FDA has approved Neuralink’s experimental brain chip for a second human patient after the team proposed a fix to the electrode’s retreat.
Neuralink went ahead with its human trials, fully knowing that the neurochip’s wires retracted, according to Reuters.
Neuralink’s PRIME study faces a setback as Noland Arbaugh's first in-human brain implant exhibits mechanical issues.
